The prognostic value of tumor PD-L1 status in patients with metastatic prostate cancer

The prognostic value of tumor PD-L1 status in patients with metastatic prostate cancer

Background.New potential biomarker for patients with metastatic hormone-naive prostate cancer (PCa) might be detection of programmed death ligand 1 (PD-L1) expression in tumor which is associated with worsened results of treatment and decreased survival in patients with pancreatic cancer, lung cance...

Full description

Bibliographic Details
Main Authors: V. B. Matveev, A. A. Kirichek, V. M. Safronova, N. V. Kokosadze, O. A. Khalmurzaev, B. Sh. Kamolov, L. N. Liubchenko
Format: Article
Language:Russian
Published: ABV-press 2019-04-01
Series:Onkourologiâ
Subjects:
metastatic prostate cancer
biomarker
pd-l1
hormonal therapy
time to castration resistance
survival
poor prognosis
Online Access:https://oncourology.abvpress.ru/oncur/article/view/915

Internet

https://oncourology.abvpress.ru/oncur/article/view/915

Similar Items